Shenyang Pharmaceutical University Patent applications |
Patent application number | Title | Published |
20130225500 | ANALGESIC ACTIVE PEPTIDE VGG, PREPARATION AND USE THEREOF - The present invention provides an active peptide purified from scorpions, and derivatives, analogues and active fragment which are produced by using genetic engineering technology. The analgesic active peptide VGG is extracted, separated and purified from scorpion, and its amino acid sequence is shown as below: | 08-29-2013 |
20130096112 | FURO[3,2-G]CHROMENE COMPOUNDS AND USES THEREOF - Disclosed are furo[3,2-g]chromene derivatives represented by formula (I), stereoisomers, pharmaceutically acceptable salts, and pharmaceutical compositions thereof, as well as uses thereof as estrogen receptor modulators. | 04-18-2013 |
20110183972 | AROMATIC RING FUSED TRIAZINE DERIVATIVES AND USES THEREOF - The invention belongs to pharmaceutical field. The invention relates to the compounds according to Formula I, including their optically active forms, pharmaceutically acceptable salts or hydrates, and the pharmaceutical composition comprising thereof as active ingredient; uses in the preparation of vascular endothelial growth factor receptor tyrosine kinase inhibitors, and uses in the preparation of medicament for the treatment and/or prevention of cancer. | 07-28-2011 |
20110064794 | Drug Delivery System, its Preparation Process and Use - A protein-phospholipid dispersion preparation in a drug delivery system is provided, in which the weight ratio of protein to phospholipid is 1:300-300:1 and the particle size is between 5 nm and 1000 nm. The preparation process of the said preparation contains the mixture of protein phase and phospholipid phase and the homogenization process. The said drug delivery system can be used in many different pharmaceutical agents. | 03-17-2011 |
20110060054 | 2-METHYLENE-5-SUBSTITUTED-METHYLENECYCLOPENTANONE DERIVATIVES AND USE THEREOF - The invention relates to 2-methylene-5-substituted-methylenecyclopentanone derivatives of formula I, and the use thereof. The derivatives of formula I as active components are useful for preparing a medicine for the treatment and/or prevention of cancer diseases such as breast cancer, lung cancer, colon cancer, rectal cancer, stomach cancer, prostate cancer, bladder cancer, uterus cancer, pancreatic cancer and ovary cancer. The active compounds of the invention may be used as an anticancer drug alone or used in combination with one or more other antitumor drugs. A combined therapy can be carried out by administrating each therapeutic component concurrently, subsequently or separately. | 03-10-2011 |
20100189596 | COMPOSITE EMULSIFIER, AN EMULSION PREPARED FROM IT AND THE PREPARATION METHOD THEREOF - A composite emulsifier, contains two or more emulsifiers selected from phospholipid, PEG emulsifier and poloxamer-like substance, and may contain cryoprotectant. An emulsion prepared from the composite emulsifier and a preparation method of the emulsion. | 07-29-2010 |
20100022656 | OPTICALLY ACTIVE PHENYLETHANOL AMINES AND PREPARING METHOD THEREOF - The invention provides compounds of formula (I) having (−) or (+) configuration, or pharmaceutically acceptable salts thereof, wherein R | 01-28-2010 |